Shares of Kinaxis Inc. (TSE:KXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is C$221.43.
A number of equities analysts have issued reports on KXS shares. Scotiabank raised their target price on shares of Kinaxis from C$225.00 to C$240.00 and gave the stock an “outperform” rating in a report on Friday, August 8th. Stifel Nicolaus raised their price target on shares of Kinaxis from C$225.00 to C$245.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Royal Bank Of Canada raised their price target on shares of Kinaxis from C$225.00 to C$235.00 in a research note on Friday, August 8th. Finally, TD Securities raised their price target on shares of Kinaxis from C$190.00 to C$225.00 and gave the company a “buy” rating in a research note on Friday, October 3rd.
View Our Latest Analysis on KXS
Insider Buying and Selling at Kinaxis
Kinaxis Stock Performance
Shares of TSE KXS opened at C$182.12 on Friday. The company has a quick ratio of 2.29, a current ratio of 1.89 and a debt-to-equity ratio of 12.12. The firm’s 50-day moving average price is C$188.94 and its two-hundred day moving average price is C$189.60. Kinaxis has a 52-week low of C$149.96 and a 52-week high of C$212.45. The stock has a market capitalization of C$5.15 billion, a P/E ratio of 211.77, a P/E/G ratio of 3.60 and a beta of 0.77.
About Kinaxis
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm’s flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
See Also
- Five stocks we like better than Kinaxis
- Insider Buying Explained: What Investors Need to Know
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- 5 discounted opportunities for dividend growth investors
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- Overbought Stocks Explained: Should You Trade Them?
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.